Fei Tang

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Acute Ischemic Stroke

Top Venues

Clinical and translational science

Journal of clinical pharmacology

Boehringer Ingelheim Pharmaceuticals Inc

University of Kentucky (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Boehringer Ingelheim Pharmaceuticals Inc May 15 2018 - Aug 23 2018

United States

Pharmacometrics Intern :: Translational Medicine and Clinical Pharmacology

Education History

University of Kentucky Jul 01 2016

United States

PHD :: Pharmaceutical Sciences

University of Minnesota Sep 01 2012 - May 13 2016

United States

PHD :: Pharmacy

Publications

Fei Tang, Rebecca Kunder, Tom Chu, Avis Hains, Allen Nguyen, Jacqueline M McBride, Yu Zhong, Sara Santagostino, Maria Wilson, Abigail Trenchak, Liuxi Chen, Justin Ly, Anita Moein, Nicholas Lewin-Koh, Vibha Raghavan, Uyi Osaghae, Chris Wynne, Ryan Owen, David E Place
First-in-human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC-2394, in healthy volunteers. Clinical and translational science (2023)
Fei Tang, Jurgen Langenhorst, Steve Dang, Nastya Kassir, Ryan Owen, Barbara Purdon, Mats O Magnusson, Rong Deng
Population Pharmacokinetics of Tenecteplase in Patients With Acute Myocardial Infarction and Application to Patients With Acute Ischemic Stroke. Journal of clinical pharmacology (2022)
Yixuan Zou, Fei Tang, Jeffery C Talbert, Chee M Ng
Using medical claims database to develop a population disease progression model for leuprorelin-treated subjects with hormone-sensitive prostate cancer. PloS one 15 (3) (2020)